Study on Aspirin Versus Placebo in Resected Colon Cancer With PI3K Mutation Stage III or II High Risk

NCT02945033 · clinicaltrials.gov ↗

PHASE3

Phase

RECRUITING

Status

264

Enrollment

OTHER

Sponsor class

Conditions

Colorectal Cancer

Interventions

DRUG: aspirin intake
DRUG: placebo intake
PROCEDURE: Surgical resection of colonic adenocarcinoma stage III or II high risk
BIOLOGICAL: Molecular analysis of exon 9 and 20 of PI3K
BIOLOGICAL: blood intake

Sponsor

University Hospital, Rouen

Collaborators

[object Object]